A mouse model of orthotopic vascularized aerated lung transplantation

American Journal of Transplantation

Volumn 7, Issue 6, 2007, Pages 1672-1679

  Okazaki, M ^a   Krupnick, A S ^a   Kornfeld, C G ^a   Lai, J M ^a   Ritter, J H ^a   Richardson, S B ^a   Huang, H J ^a   Das, N A ^a   Patterson, G A ^a   Gelman, A E ^a   Kreisel, D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung transplantation; Mice; Surgical technique

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GRAFT RECIPIENT; HISTOPATHOLOGY; IMMUNE RESPONSE; ISOGRAFT; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PHYSIOLOGY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; T LYMPHOCYTE; VASCULARIZATION;

ANIMALS; LUNG TRANSPLANTATION; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY VEINS; TRANSPLANTATION, ISOGENEIC;

EID: 34248631098     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01819.x     Document Type: Article

References (35)

1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 2006 25 : 880 892.
2. Chan A, Allen R. Bronchiolitis obliterans: An update. Curr Opin Pulm Med 2004 10 : 133 141.
3. Yamane M, Liu M, Kaneda H, Uhlig S, Waddell TK, Keshavjee S. Reperfusion-induced gene expression profiles in rat lung transplantation. Am J Transplant 2005 5 : 2160 2169.
4. Shoji T, Wain JC, Houser SL et al. Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swine. Am J Transplant 2005 5 : 1626 1634.
5. Nakashima S, Soong TR, Fox-Talbot K et al. Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts. Am J Transplant 2005 5 : 694 701.
6. Hashimoto N, Takeyoshi I, Yoshinari D et al. Effects of a p 38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1. Transplantation 2002 74 : 320 326.
7. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993 142 : 1945 1951.
8. Maruyama T, Jaramillo A, Narayanan K, Higuchi T, Mohanakumar T. Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant 2005 5 : 2126 2134.
9. Higuchi T, Maruyama T, Jaramillo A, Mohanakumar T. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen. J Immunol 2005 174 : 1871 1878.
10. Richards DM, Dalheimer SL, Hertz MI, Mueller DL. Trachea allograft class I molecules directly activate and retain CD8+ T cells that cause obliterative airways disease. J Immunol 2003 171 : 6919 6928.
11. Fernandez FG, Jaramillo A, Chen C et al. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 2004 4 : 319 325.
12. Minamoto K, Pinsky DJ. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J Exp Med 2002 196 : 1321 1333.
13. Marck KW, Wildevuur CR. Lung transplantation in the rat: I. Technique and survival. Ann Thorac Surg 1982 34 : 74 80.
14. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996 15 : 1 15.
15. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996 381 : 434 438.
16. Birsan T, Hausen B, Higgins JP et al. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Transplantation 2003 75 : 2106 2113.
17. Vincenti F, Larsen C, Durrbach A et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005 353 : 770 781.
18. Jones ND, Turvey SE, Van Maurik A et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001 166 : 2824 2830.
19. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994 19 : 916 924.
20. Mazariegos GV, Reyes J, Marino IR et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 63 : 243 249.
21. Khalifah AP, Hachem RR, Chakinala MM et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004 170 : 181 187.
22. Khalifah AP, Hachem RR, Chakinala MM et al. Minimal acute rejection after lung transplantation: A risk for bronchiolitis obliterans syndrome. Am J Transplant 2005 5 : 2022 2030.
23. Fiser SM, Tribble CG, Long SM et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002 73 : 1041 1047.
24. Cantu E, 3rd, Appel JZ, 3rd, Hartwig MG et al. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004 78 : 1142 1151.
25. Goldstein DR, Palmer SM. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation. J Heart Lung Transplant 2005 24 : 1721 1729.
26. Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005 5 : 2031 2036.
27. Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006 6 : 2622 2635.
28. Palmer SM, Burch LH, Trindade AJ et al. Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med 2005 171 : 780 785.
29. de Perrot M, Young K, Imai Y et al. Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 2003 171 : 4995 5002.
30. Slebos DJ, Scholma J, Boezen HM et al. Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with a good outcome after lung transplantation. Am J Respir Crit Care Med 2002 165 : 501 507.
31. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J Immunol 2003 171 : 3128 3135.
32. Oriss TB, Ostroukhova M, Seguin-Devaux C et al. Dynamics of dendritic cell phenotype and interactions with CD4+ T cells in airway inflammation and tolerance. J Immunol 2005 174 : 854 863.
33. Fujita T, Toda K, Karimova A et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nature Medicine 2001 7 : 598 604.
34. Geudens N, Vanaudenaerde BM, Neyrinck AP et al. Impact of warm ischemia on different leukocytes in bronchoalveolar lavage from mouse lung: Possible new targets to condition the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2006 25 : 839 846.
35. de Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004 200 : 89 98.